Vajen, Tanja
Koenen, Rory R. http://orcid.org/0000-0002-9955-9730
Werner, Isabella
Staudt, Mareike
Projahn, Delia
Curaj, Adelina
Sönmez, Tolga Taha
Simsekyilmaz, Sakine
Schumacher, David
Möllmann, Julia
Hackeng, Tilman M.
Hundelshausen, Philipp von
Weber, Christian
Liehn, Elisa A. http://orcid.org/0000-0002-1253-3272
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB1123/A2, SFB1123/A2)
ZonMw (016.126.358)
Landsteiner Foundation for Blood Transfusion Research (1638)
EC | European Research Council (249929)
Article History
Received: 21 November 2017
Accepted: 29 June 2018
First Online: 13 July 2018
Competing Interests
: These authors declare competing financial interests: Christian Weber, Philipp von Hundelshausen, and Rory R. Koenen are shareholders of Carolus Therapeutics Inc., San Diego, CA, now Anemot Therapeutics Inc, Raleigh-Durham, NC. All other authors have nothing to disclose.